Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicentre, multinational prospective observational imaging biomarker study in early stage Huntington's disease (HD) patients to assess imaging techniques and parameters able to support efficacy studies with SEN0014196 in HD patients during Phase II and III studies.

Next Previous
Trial Profile

A multicentre, multinational prospective observational imaging biomarker study in early stage Huntington's disease (HD) patients to assess imaging techniques and parameters able to support efficacy studies with SEN0014196 in HD patients during Phase II and III studies.

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 07 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Selisistat (Primary)
  • Indications Huntington's disease
  • Focus Biomarker; Pharmacodynamics
  • Acronyms PADDINGTON
  • Sponsors Siena Biotech

    • Most Recent Events

    • 13 Jan 2012 United Kingdom Clinical Research Network reports accrual to date changed from 1% to 11%.
    • 02 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Dec 2011 Additional lead trial centre, investigator and actual patient no is 55 identified as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top